| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer
1 company
Huntsman Carole is a Chief Commercial Officer at Madrigal Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $6.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | MDGL Madrigal Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 419 | $431.94 | $180,982.86 | -3.2% | - | - | |
| Nov 21, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 1,958 | $553.11 | $1,082,986.25 | -1.7% | -20.3% | - | |
| Mar 3, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 1,834 | $325.98 | $597,839.68 | -2.1% | -13.0% | +35.9% | |
| Jan 24, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 347 | $335.24 | $116,328.28 | -3.2% | -2.5% | +46.4% | |
| Nov 21, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Chief Commercial Officer | Sell | 688 | $316.92 | $218,040.96 | -6.0% | +4.4% | +66.4% |